Press release
Gene Therapy For Retinal Diseases Market Exclusive Report with Detailed Study Analysis
The Gene Therapy For Retinal Diseases Market is expected to grow at an 8.0 % CAGR during the forecast period for 2023-2031.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1157
Gene therapy for retinal diseases offers a groundbreaking approach to treating inherited retinal disorders (IRDs) by directly targeting their underlying genetic causes. This innovative treatment strategy focuses on delivering functional gene copies, correcting mutations through gene editing, or silencing defective genes using advanced technologies like AAV vectors and CRISPR-Cas9 systems. These therapies specifically target key retinal cells, including photoreceptors & retinal pigment epithelium (RPE) cells, with the goal of preventing or restoring vision in conditions such as retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease, and choroideremia (CHM).
The retina's unique characteristics including its immune-privileged status and accessibility for monitoring make it especially suitable for gene-based interventions. Current therapeutic approaches encompass gene augmentation, precise gene editing, and RNA-targeted strategies, with notable clinical successes like Luxturna paving the way for over 20 additional therapies currently in development.
List of Prominent Players in the Gene Therapy For Retinal Diseases Market:
• Applied Genetic Technologies Corporation
• Adverum Biotechnologies
• ProQR Therapeutics
• MeiraGTx Limited.
• Oxford BioMedica
• Horama S.A.
• Gensight Biologics
• Regenxbio Inc.
• Spark Therapeutics, Inc.
• Genzyme (Sanofi)
• Novartis Pharmaceuticals
• Nightstar Therapeutics (Biogen)
• Hemera Biosciences
• ViGeneron GmbH
• Allergan
• Eyevensys
• Clearside Biomedical
• IVERIC bio, Inc.
• Other Prominent Players
Market Dynamics:
Market Drivers
The rising diagnosis rates of inherited retinal diseases (IRDs) like retinitis pigmentosa, Leber congenital amaurosis, and Stargardt disease are fueling demand for gene therapies. Increased availability of genetic testing and greater disease awareness are helping identify more patients who could benefit from these treatments.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1157
Market Challenges
Despite their potential, retinal gene therapies face significant barriers. The extremely high costs of these treatments put them out of reach for many patients, particularly where insurance coverage is limited. Treatment availability is also concentrated in certain regions, leaving patients in low and middle income countries with few options. These access issues are especially concerning for progressive retinal disorders, where early treatment is crucial, as delays can lead to irreversible vision loss.
Regional Trends
North America currently dominates the retinal gene therapy market, supported by strong healthcare infrastructure, substantial R&D investment, and favourable regulatory policies. The region benefits from widespread genetic testing capabilities and insurance coverage for approved therapies like Luxturna. Meanwhile, the Asia Pacific region is emerging as the fastest-growing market, driven by increasing investments in genetic medicine and growing awareness of IRDs across major economies.
Recent Developments:
• In October 2023, Spark Therapeutics and SpliceBio declared a partnership and licensing deal whereby SpliceBio will employ its unique protein splicing platform to create a gene therapy for the treatment of an inherited retinal condition. The illness target's specifics were not revealed. The deal calls for both businesses to work together on a research project using SpliceBio's technological platform.
Curious about this latest version of the report? @
https://www.insightaceanalytic.com/customization/1157
Segmentation of Gene Therapy For Retinal Diseases Market.
Global Gene Therapy For Retinal Diseases Market - By Indication
• Choroideremia (CHM)
• Leber congenital amaurosis
• Leber's hereditary optic neuropathy
• X-linked retinitis pigmentosa
• Other Indication
Global Gene Therapy For Retinal Diseases Market - By Region
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get More Information : @
https://www.insightaceanalytic.com/report/global-gene-therapy-for-retinal-diseases-market-/1157
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Therapy For Retinal Diseases Market Exclusive Report with Detailed Study Analysis here
News-ID: 4168524 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Data Center Rear Door Heat Exchanger (RDHx) Cooling Market Exclusive Report on t …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Data Center Rear Door Heat Exchanger (RDHx) Cooling Market- (By Type (Active RDHx, Passive RDHx), By Application (Hyperscale Data Centers, Enterprise Data Centers, Colocation and Retail Data Centers, Others), By Heat Distribution (Open Loop, Close Loop)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Data Center…
Complex Iron Desulfurization Catalyst Market Report Latest Trends and Future Opp …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Complex Iron Desulfurization Catalyst Market- (By Form (Dry, Wet), By Application (Refinery Gas Treatment, Natural Gas Processing, Biogas Treatment, Ammonia Synthesis, Others), By End-User (Water Treatment, Oil and Gas, Chemical Industry, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Complex Iron Desulfurization Catalyst Market Size…
Bioprocessing Equipment Market Current Scenario with Future Aspect Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioprocessing Equipment Market - product type (control and monitoring systems, Bioreactors, Filtration Systems, Fermenters, and Support Equipment), application (Food & Beverage, Pharmaceutical & Biopharmaceutical, Environmental, Agricultural, Research & Development, and Industrial Biotechnology), indication, and end-user, Trends, Industry Competition Analysis, Revenue And Forecast To 2034."
The global Bioprocessing Equipment Market Size is valued at USD 64.6 Bn…
AI in Climate Change Mitigation Market Deep Research Report with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI in Climate Change Mitigation Market - By Component (Hardware, Software, Services), By Deployment Mode (Cloud-Based, On-Premises), By End-Use Industry (Energy & Utilities, Transportation, Agriculture, Construction, Government and Public Sectors), By Application (Carbon Footprint Management, Energy Optimization, Climate Risk Assessment, Sustainable Agriculture), Trends, Industry Competition Analysis, Revenue And Forecast To 2034."
The global AI in…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
